Buprenorphine Market Recent Research: Market Size, Trends & Forecasts 2021-2027
An extensive study offering forecast assessment onBuprenorphine Market has been broadcasted. By correlating the historical data with key market dynamics, our analysts can make highly astute projections. The report includes a thorough analysis of the global Buprenorphine Market segmented by type, application, and region. Trends and opportunities are highlighted coupled with the market share of companies as well as their valuation in the market.
Global Buprenorphine Market, by Application (Analgesic and Opioid Antagonist), by Route of Administration (Injectables, Sublingual, and Transdermal), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) is expected to be accounted at US$ 3,681.9 million in 2020 and is expected to register a CAGR of 14.5% over the forecast period (2020-2027), as highlighted in a new report published by Coherent Market Insights.
Market players are introducing new products in order to fuel the global buprenorphine market growth.
The major players are concentrating their efforts on the research and development of new products to meet patients’ vital unmet needs, which is expected to drive growth of the global buprenorphine market over the forecast period. For instance, in November 2017, Indivior PLC received approval from the U.S. Food and Drug Administration for SUBLOCADE (Buprenorphine Extended-Release) indicated for treatment of moderate to severe opioid use disorder. However, in February 2019, Indivior PLC announced the launch of an authorized generic version of SUBOXONE (buprenorphine and naloxone) in the U.S. which will be marketed by Sandoz Inc.
Furthermore, a rise in the geriatric population is expected to pose drive growth of the global buprenorphine market by increasing the prevalence rate of osteoarthritis and osteoporosis. For instance, in August 2017, according to National Center for Biotechnology Information (NCBI), report published, knee osteoarthritis accounts for around 80% of the total disease burden and affects around 19% of American adults aged 45 years and above.
Impact of Coronavirus (COVID-19) Pandemic
The COVID-19 virus has spread to over 100 countries since its outbreak in December 2019 and the World Health Organization has declared it a public health emergency. For instance, according to the World Health Organization’s report, the manifestation of coronavirus disease (COVID-19) has resulted in over 30.6 million infected individuals worldwide as of 21st September 2020.
COVID-19 has affected the economy in three ways: directly influencing supply and demand, causing distribution chain disturbances, and having a financial impact on businesses and financial markets. Several countries, including Saudi Arabia, the United Arab Emirates, Egypt, and others, are experiencing difficulties transporting such drugs from one location to another due to lockdowns.
Furthermore, the COVID-19 epidemic has hampered the availability of raw materials and potent compounds, used in the manufacture of drugs like Buprenorphine, which could disrupt the global buprenorphine market growth in the near future.
Major market players are focusing on strategies such as mergers and acquisitions due to expand their product range. For instance, in December 2016, Luye Pharma Group Ltd. acquired Acino’s transdermal drug delivery systems (TDS) business, which includes formulation of Rivastigmine, Buprenorphine, Fentanyl and fertility control patch.
Key Takeaways of the Global Buprenorphine Market:
-
The global buprenorphine market is expected to register a CAGR around 14.5% over the forecast period due to growing incidence of abuse of heroin and drug, opioid addiction, chronic and acute pain control, osteoarthritis, and chronic pain associated with cancer treatment. For instance, in September 2017, according to the Hindawi Pain Research and Management Journal, an estimated 30 to 50% cases of chronic pain globally.
-
On the basis of application type, the opioid antagonist segment held a dominant position in the global buprenorphine market in 2019, due to its significance in the treatment of opioid addiction.
-
Among route of administration, the sublingual segment held a dominant position in the global buprenorphine market in 2019, due to the majority of newly released generics are in the form of sublingual films used to treat opioid addiction.
-
On the basis of distribution channel, hospital pharmacy segment held a dominant position in the global buprenorphine market in 2019, as the majority of cancer cases and osteoarthritis cases are reported at hospitals. Furthermore, the majority of important cancer treatments are carried out in hospitals.
-
Key players dominating in the global buprenorphine market such as Sanofi, Mallinckrodt, Johnson Matthey, Unichem Laboratories, Noramco, Faran Shimi Pharmaceutical Co., Resonance-labs, Arevipharma GmbH, Micro Orgo Chem, Rusan Pharma, Sun Pharmaceutical Industries Ltd. and Siegfried.
Major Key Players Include In Buprenorphine Market: Siegfried, Sanofi, Johnson Matthey, Mallinckrodt, Noramco, Unichem Laboratories, Arevipharma GmbH, Resonance-labs, Sun Pharmaceutical Industries Ltd., Rusan Pharma, Micro Orgo Chem, and Faran Shimi Pharmaceutical Co.
Buy instant copy of this research report with Flat US $ 2000 Off@ – https://www.coherentmarketinsights.com/promo/buynow/4237
Main points in Buprenorphine Market Report Table of Content
Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 Buprenorphine Market Size Analysis from 2021 to 2027
11.6 COVID-19 Outbreak: Buprenorphine Industry Impact
Chapter 2 Global Buprenorphine Competition by Types, Applications, and Top Regions and Countries
2.1 Global Buprenorphine (Volume and Value) by Type
2.3 Global Buprenorphine (Volume and Value) by Regions
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.2 Regional Production Market Analysis
Chapter 4 Global Buprenorphine Sales, Consumption, Export, Import by Regions (2016-2021)
Chapter 5 North America Buprenorphine Market Analysis
Chapter 6 East Asia Buprenorphine Market Analysis
Chapter 7 Europe Buprenorphine Market Analysis
Chapter 8 South Asia Buprenorphine Market Analysis
Chapter 9 Southeast Asia Buprenorphine Market Analysis
Chapter 10 Middle East Buprenorphine Market Analysis
Chapter 11 Africa Buprenorphine Market Analysis
Chapter 12 Oceania Buprenorphine Market Analysis
Chapter 13 South America Buprenorphine Market Analysis
Chapter 14 Company Profiles and Key Figures in Buprenorphine Business
Chapter 15 Global Buprenorphine Market Forecast (2021-2027)
Chapter 16 Conclusions
Research Methodology
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
Contact Us
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Phone: US +12067016702 / UK +4402081334027
Email: sales@coherentmarketinsights.com
Editor Details
-
Company:
- CDN Newswire
